Inquiry Basket
CAS No.:
Cat No.: BADC-01868
4.5 
KY371 is a click chemistry reagent containing an alkyne group. It can combine with proteomic analysis of targeted protein to study glycosidases.
Structure of
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
KY371 is a novel bioactive compound with promising applications in various scientific fields. Here are some key applications of KY371:
Cancer Research: KY371 has shown potential as an anti-cancer agent due to its ability to selectively target and inhibit cancer cell growth. Researchers are exploring its effects on apoptosis pathways to better understand its therapeutic potential in oncology. This compound could be pivotal in developing new cancer treatments that are more effective and less toxic than traditional chemotherapeutics.
Neuroscience: In neuroscience, KY371 is being studied for its neuroprotective properties and its ability to modulate neurotransmitter release. By investigating its influence on neural pathways, scientists aim to uncover potential treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. KY371 offers hope for therapies that slow disease progression and improve cognitive function.
Antimicrobial Studies: KY371 exhibits promising antimicrobial activity against a range of bacterial and fungal pathogens. Researchers are evaluating its mechanism of action to develop new antibiotics in an era of increasing antibiotic resistance. Understanding how KY371 disrupts microbial viability could lead to the development of potent antimicrobial strategies.
Inflammatory Diseases: KY371 is also under investigation for its anti-inflammatory effects, making it a candidate for treating chronic inflammatory diseases. By modulating inflammatory signaling pathways, KY371 may provide relief for conditions such as rheumatoid arthritis and inflammatory bowel disease. Continued research could establish KY371 as a key player in anti-inflammatory drug development.
KY371
Required fields are marked with *
KY371
Required fields are marked with *
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
